Reduction by SEA0400 of myocardial ischemia-induced cytoplasmic and mitochondrial Ca2+ overload

被引:30
|
作者
Namekata, Iyuki
Shimada, Hideaki
Kawanishi, Toru
Tanaka, Hikaru
Shigenobu, Koki
机构
[1] Toho Univ, Fac Pharmaceut Sci, Dept Pharmacol, Chiba 2748510, Japan
[2] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo 1588501, Japan
关键词
heart; ischemia-reperfusion; sodium-calcium exchanger; mitochondria; SEA0400;
D O I
10.1016/j.ejphar.2006.06.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cardioprotective effects of SEA0400, a novel Na+-Ca2+ exchanger inhibitor, were examined in isolated guinea pig myocardial tissue and ventricular myocytes. In a coronary-perfused right ventricular tissue preparation, SEA0400 had no cardiosuppressive effect during normoxia and experimental ischemia, but enhanced the recovery of contractile force during reperfusion. SEA0400 had no effect on tissue ATP content during normoxia, but attenuated its decrease during ischemia. Treatment of ventricular myocytes with an ischemia mimetic solution (high K+, glucose free, pH 6.0, gassed with N-2) resulted in the depolarization of the mitochondrial membrane potential and an increase in cytoplasmic and mitochondrial Ca2+ concentration, which had a similar time course. SEA0400 significantly delayed these changes. These results suggest that SEA0400 maintains mitochondrial function and tissue ATP content during ischemia through the inhibition of cytoplasmic and mitochondrial Ca2+ overload. (c) 2006 Elsevier B.V All rights reserved.
引用
收藏
页码:108 / 115
页数:8
相关论文
共 50 条
  • [1] SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes
    Wang, J.
    Zhang, Z.
    Hu, Y.
    Hou, X.
    Cui, Q.
    Zang, Y.
    Wang, C.
    PHYSIOLOGICAL RESEARCH, 2007, 56 (01) : 17 - 23
  • [2] SEA0400 reduces calcium overload during ischemia/reperfusion by inhibition of Na+/Ca2+ exchange current in mouse ventricular myocytes
    Xu, HT
    Wang, J
    Liu, YM
    Cao, Y
    Tian, HT
    DRUG DEVELOPMENT RESEARCH, 2005, 66 (03) : 230 - 231
  • [3] Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia-reperfusion injuries
    Takahashi, K
    Takahashi, T
    Suzuki, T
    Onishi, M
    Tanaka, Y
    Hamano-Takahashi, A
    Ota, T
    Kameo, K
    Matsuda, T
    Baba, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 458 (1-2) : 155 - 162
  • [4] Cardioprotective effect of SEA0400, a selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia-reperfusion injury in rats
    Yoshiyama, M
    Nakamura, Y
    Omura, T
    Hayashi, T
    Takagi, Y
    Hasegawa, T
    Nishioka, H
    Takeuchi, K
    Iwao, H
    Yoshikawa, J
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 95 (02) : 196 - 202
  • [6] A novel and selective Na+/Ca2+ exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury
    Ogata, M
    Iwamoto, T
    Tazawa, N
    Nishikawa, M
    Yamashita, J
    Takaoka, M
    Matsumura, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 478 (2-3) : 187 - 198
  • [7] Effects of SEA0400, a novel inhibitor of the Na+/Ca2+ exchanger, on myocardial stunning in anesthetized dogs
    Takahashi, T
    Takahashi, K
    Onishi, M
    Suzuki, T
    Tanaka, Y
    Ota, T
    Yoshida, S
    Nakaike, S
    Matsuda, T
    Baba, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 505 (1-3) : 163 - 168
  • [8] Inhibitory mechanism of a novel Na+/Ca2+ exchange inhibitor SEA0400
    Iwamoto, T
    Kita, S
    Uehara, A
    Shigekawa, M
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 189A - 189A
  • [9] Attenuation of mitochondrial,but not cytosolic,Ca2+ overload reduces myocardial injury induced by ischemia and reperfusion
    Kenneth WL KAM
    James SK SHAM
    Tlak-ming WONG
    ActaPharmacologicaSinica, 2006, (07) : 911 - 918
  • [10] Attenuation of mitochondrial, but not cytosolic, Ca2+ overload reduces myocardial injury induced by ischemia and reperfusion
    Cao, Chun-mei
    Yan, Wing-yee
    Liu, Jing
    Kam, Kenneth W. L.
    Zhan, Shi-zhong
    Sham, James S. K.
    Wong, Tak-ming
    ACTA PHARMACOLOGICA SINICA, 2006, 27 (07) : 911 - 918